1. Introduction
1.1. Market Scope and Segmental Definition
1.2. Assumptions & Limitation
2. Research Methodology
2.1. Research Approach & Data Sources
2.2. Forecasting Model
3. Executive Summary
3.1. Analyst?s Insights
3.2. Top Line Market estimation
3.3. Value Chain Analysis
4. Market Forces
4.1. Key Industry Drivers, Restraints and Opportunities
4.2. Industry Trends
5. Market Outlook by Service (Current size & future market estimates)
5.1. Manufacturing
5.1.1. API/Bulk Drugs
5.1.2. Advanced Drug Delivery Formulations
5.1.3. Packaging
5.1.4. Finished Dose Formulations
5.1.5. Solid, Liquid and Semi-solid formulations
5.2. Research
5.2.1. Oncolgy
5.2.2. Vaccines
5.2.3. Inflammation & Immunology
5.2.4. Cardiology
5.2.5. Neuroscience
6. Market Outlook by End-use (Current size & future market estimates)
6.1. Big Pharma
6.2. Small & Mid-size Pharma
6.3. Generic Pharmaceutical Companies
6.4. Others
7. Market Outlook by Regions (Current size & future market estimates)
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. France
7.3. Asia Pacific
7.3.1. China
7.3.2. India
7.4. Latin America
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Colombia
7.4.4. Argentina
7.4.5. Chile
7.4.5. Venezuela
7.5. MEA
7.5.1. South Africa
8. Competitive Landscape
8.1. Market Share/Market Ranking Analysis
8.2. Competitive Market Scenario (New Product Innovations, Key Strategic Moves & Partnerships, Start-ups Ecosystem)
9. Company Profiles
Includes: Company Overview, Product & Services Offerings, Financials (only for listed companies), New Developments and Innovation)
9.1. Boehringer Ingelheim GmbH
9.2. Lonza
9.3. Grifols S.A
9.4. Jubilant Life Sciences Limited
9.5. Pfizer, Inc. (Pfizer CenterOne)
9.6. Charles River Laboratories International, Inc.
9.7. Albany Molecular Research, Inc.
9.8. Covance, Inc. (Labcorp)
9.9. IQVIA (QuintilesIMS)
9.10. Baxter BioPharma Solutions
9.11. Aenova Holding GmbH